MedPath

Diazepam Intensol

Diazepam ™ Oral Solution (Concentrate), CIV 25 mg per 5 mL (5 mg/mL) Rx only

Approved
Approval ID

1aaf9375-ae3d-4fed-9cd1-24102e00be1a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 16, 2022

Manufacturers
FDA

Hikma Pharmaceuticals USA Inc.

DUNS: 080189610

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Diazepam Intensol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0054-3185
Application NumberANDA071415
Product Classification
M
Marketing Category
C73584
G
Generic Name
Diazepam Intensol
Product Specifications
Route of AdministrationORAL
Effective DateAugust 30, 2022
FDA Product Classification

INGREDIENTS (7)

DIAZEPAMActive
Quantity: 5 mg in 1 mL
Code: Q3JTX2Q7TU
Classification: ACTIB
ALCOHOLInactive
Quantity: 190 mg in 1 mL
Code: 3K9958V90M
Classification: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQ
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
SUCCINIC ACIDInactive
Code: AB6MNQ6J6L
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Diazepam Intensol - FDA Drug Approval Details